Phase 3 Study of Sofosbuvir and Ribavirin

NCT01497366 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

527

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Sofosbuvir
DRUG: PEG
DRUG: RBV

Sponsor

Gilead Sciences